Insiders · Profile

CASAMENTO CHARLES J

Director at RELMADA THERAPEUTICS · Director at GridAI Technologies · Director at Eton Pharmaceuticals. Filing since 14 Dec 2015. CIK 0001117167

Company
Date
Role
Action
Shares
Amount
Of holding
9 Sep 2024
Director
Bought
13,000
$33.28K
opened
15 Sep 2023
Director
Sold at will
10
$4.30
0.2%
31 Aug 2023
Director
Sold at will
6,053
$1.82K
49.8%
1 Apr 2022
Director
Sold, plan not stated
19,800
$574.20K
100%
22 Sep 2021
Director
Sold, plan not stated
6,600
$191.40K
39.8%
15 Jul 2021
Director
Sold, plan not stated
3,300
$104.09K
41.3%
1 Jun 2021
Director
Sold, plan not stated
3,000
$100.02K
30.2%
3 May 2021
Director
Sold, plan not stated
3,000
$114.65K
23.2%
1 Apr 2021
Director
Sold, plan not stated
3,000
$106.28K
18.8%
1 Mar 2021
Director
Sold, plan not stated
3,000
$101.62K
15.8%
1 Feb 2021
Director
Sold, plan not stated
3,000
$100.90K
13.7%
4 Jan 2021
Director
Sold, plan not stated
3,000
$96.34K
12.0%
1 Dec 2020
Director
Sold, plan not stated
3,000
$107.22K
10.7%
2 Nov 2020
Director
Sold, plan not stated
3,000
$90.86K
5.8%
1 Oct 2020
Director
Sold, plan not stated
3,000
$113.96K
5.4%
1 Sep 2020
Director
Sold, plan not stated
3,000
$104.21K
5.2%
3 Aug 2020
Director
Sold, plan not stated
3,000
$107.21K
8.1%
1 Jul 2020
Director
Sold, plan not stated
3,000
$131.68K
7.5%
9 Aug 2019
Director
Bought
3,500
$21.37K
5.1%
28 Dec 2018
Director
Bought
9,000
$12.69K
18.9%
15 Nov 2018
Director
Bought
5,000
$30.00K
7.9%
14 Dec 2015
Director
Bought
4,200
$12.46K
opened
22 decisions on file.